Zhang L P, Kline R H, Deevska G, Ma F, Nikolova-Karakashian M, Westlund K N
Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40526-0298, United States.
Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40526-0298, United States.
Neuroscience. 2015 Dec 17;311:166-79. doi: 10.1016/j.neuroscience.2015.10.028. Epub 2015 Oct 19.
The pathogenesis of pain in chronic pancreatitis is poorly understood, and its treatment can be a major clinical challenge. Surgical and other invasive methods have variable outcomes that can be unsatisfactory. Therefore, there is a great need for further discovery of the pathogenesis of pancreatitis pain and new therapeutic targets. Human and animal studies indicate a critical role for oxidative stress and activation of transient receptor potential (TRP) cation channel subfamily members TRPV1 and TRPA1 on pancreatic nociceptors in sensitization mechanisms that result in pain. However, the in vivo role of transient receptor potential cation channel subfamily V member 4 (TRPV4) in chronic pancreatitis needs further evaluation. The present study characterized a rat alcohol/high fat diet (AHF)-induced chronic pancreatitis model with hypersensitivity, fibrotic pathology, and fat vacuolization consistent with the clinical syndrome. The rats with AHF-induced pancreatitis develop referred visceral pain-like behaviors, i.e. decreased hindpaw mechanical thresholds and shortened abdominal and hindpaw withdrawal latency to heat. In this study, oxidative stress was characterized as well as the role of TRPV4 in chronic visceral hypersensitivity. Lipid peroxidase and oxidative stress were indicated by increased plasma thiobarbituric acid reactive substances (TBARS) and diminished pancreatic manganese superoxide dismutase (MnSOD). The secondary sensitization associated with AHF-induced pancreatitis was effectively alleviated by the TRPV4 antagonist, HC 067047. Similarity of the results to those with the peripherally restricted μ-opiate receptor agonist, loperamide, suggested TRPV4 channel activated peripheral sensitization. This study using a reliable model that provides pre-clinical correlates of human chronic pancreatitis provides further evidence that TRPV4 channel is a potential therapeutic target for treatment of pancreatitis pain.
慢性胰腺炎疼痛的发病机制尚不清楚,其治疗可能是一项重大的临床挑战。手术和其他侵入性方法的效果参差不齐,可能并不理想。因此,迫切需要进一步探索胰腺炎疼痛的发病机制和新的治疗靶点。人和动物研究表明,氧化应激以及瞬时受体电位(TRP)阳离子通道亚家族成员TRPV1和TRPA1在胰腺伤害感受器上的激活在导致疼痛的敏化机制中起关键作用。然而,瞬时受体电位阳离子通道亚家族V成员4(TRPV4)在慢性胰腺炎中的体内作用需要进一步评估。本研究对一种大鼠酒精/高脂饮食(AHF)诱导的慢性胰腺炎模型进行了表征,该模型具有超敏反应、纤维化病理和脂肪空泡化,与临床综合征一致。AHF诱导的胰腺炎大鼠会出现牵涉性内脏痛样行为,即后爪机械阈值降低以及腹部和后爪对热刺激的缩足潜伏期缩短。在本研究中,对氧化应激以及TRPV4在慢性内脏超敏反应中的作用进行了表征。血浆硫代巴比妥酸反应性物质(TBARS)增加和胰腺锰超氧化物歧化酶(MnSOD)减少表明存在脂质过氧化和氧化应激。TRPV4拮抗剂HC 067047有效缓解了与AHF诱导的胰腺炎相关的继发性敏化。这些结果与外周限制性μ-阿片受体激动剂洛哌丁胺的结果相似,提示TRPV4通道激活了外周敏化。本研究使用了一个可靠的模型,该模型提供了人类慢性胰腺炎的临床前相关性,进一步证明TRPV4通道是治疗胰腺炎疼痛的潜在治疗靶点。